October 12, 2019 – New York, US – In vitro diagnostics (IVD) is nowadays an indispensable medical means for human disease prevention, diagnosis and treatment, which refers to a technology for obtaining diagnostic information by testing samples (such as blood, tissue, etc.) outside the human body. About 80% of the clinical diagnosis information comes from in vitro diagnostics. The global in vitro diagnostics market amounts to about 70 billion US dollars in 2019 and will reach 93.6 billion US dollars in 2025. Facing this powerful booster for human health, Creative Biolabs launches a series of services and research tools, including discovery and development of IVD biomarkers and in vitro diagnostic antibodies respectively, to support relative projects, whatever about the disease diagnosis or therapy development.
The comprehensive service range: Monoclonal Antibody Development, Polyclonal Antibody Development, Antibody Pair Development, Recombinant Antibody Development, Antibody & Antigen Conjugation
Creative Biolabs provides monoclonal antibody (mAb), polyclonal antbody (pAb) development services adopting the most up-to-date hybridoma technology to ensure delivering full range of antibodies coming from hosts like hamster, rat, sheep, and chicken, which function significantly in basic research, therapeutics, and diagnostics. Clients can be guaranteed that the resulting antibodies are first-class, high-yield and applicable to various tests like enzyme-linked immunosorbent assay, radio immunoassay, serotyping of microorganisms, etc.
Anti-cancer drug, one of the most widely applied therapeutic fields of antibody drugs, makes antibody engineering projects popular among medicine manufacturers. To cater to clients in urgent need, Creative Biolabs, with far-fetching history in the antibody design area, offers relative proposals, including antibody pair development (mAb-mAb, mAb-pAb and pAb-pAb) and recombinant antibody development (antibody affinity maturation, antibody chimerization, antibody humanization, isotype switching, and antibody reformatting).
Creative Biolabs provides antigen & antibody conjugation services with the standard Lightning-Link kits developed by the scientific staff, which works well with all IgGs regardless of the species and will generate excellent conjugates. In addition, antibodies can be labeled with various enzymes, fluorochromes, or biotin. Services consist protein-protein conjugation, particle conjugation, oligonucleotide conjugation, biotin labeling, and so on, ensuring that all the deliveries are customizable conjugation ration and scale with full after sale support from professional team.
For years, Creative Biolabs holds the faith of “customer first” and provides discovery and development services of diagnostic antibodies for a variety of disease areas composing more than autoimmune diseases, cancer, infectious diseases, and cardiovascular diseases.
For more information accordingly, please visit https://www.creative-biolabs.com/drug-discovery/diagnostics/.
Creative Biolabs, set up in 2004 by scientists who devote themselves to the treatment of a wide variety of diseases focuses on drug discovery services through its custom-service-centered business model, whose commitment to accelerate the progress of human health motivates it to deliver global clients the best quality results to further promote the progress of biotech/pharmaceutical industries.
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email
Address:45-1 Ramsey Road
State: New York
Country: United States